Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents

…, M Lanzer, AK Mueller, G Klebe, M Schlitzer

Index: Schrader, Florian C.; Glinca, Serghei; Sattler, Julia M.; Dahse, Hans-Martin; Afanador, Gustavo A.; Prigge, Sean T.; Lanzer, Michael; Mueller, Ann-Kristin; Klebe, Gerhard; Schlitzer, Martin ChemMedChem, 2013 , vol. 8, # 3 p. 442 - 461

Full Text: HTML

Citation Number: 20

Abstract

Abstract Malaria is a potentially fatal disease caused by Plasmodium parasites and poses a major medical risk in large parts of the world. The development of new, affordable antimalarial drugs is of vital importance as there are increasing reports of resistance to the currently available therapeutics. In addition, most of the current drugs used for chemoprophylaxis merely act on parasites already replicating in the blood. At this point, a ...